APA (7th ed.) Citation

García-Corbacho, J., Indacochea, A., González Navarro, A. E., Victoria, I., Moreno, D., Pesántez, D., . . . Schettini, F. (2023). Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study. Cancer Immunology, Immunotherapy, 72(6), 1725-1726. https://doi.org/10.1007/s00262-023-03396-5

Chicago Style (17th ed.) Citation

García-Corbacho, Javier, et al. "Correction to: Determinants of Activity and Efficacy of Anti-PD1/PD-L1 Therapy in Patients with Advanced Solid Tumors Recruited in a Clinical Trials Unit: A Longitudinal Prospective Biomarker-based Study." Cancer Immunology, Immunotherapy 72, no. 6 (2023): 1725-1726. https://doi.org/10.1007/s00262-023-03396-5.

MLA (9th ed.) Citation

García-Corbacho, Javier, et al. "Correction to: Determinants of Activity and Efficacy of Anti-PD1/PD-L1 Therapy in Patients with Advanced Solid Tumors Recruited in a Clinical Trials Unit: A Longitudinal Prospective Biomarker-based Study." Cancer Immunology, Immunotherapy, vol. 72, no. 6, 2023, pp. 1725-1726, https://doi.org/10.1007/s00262-023-03396-5.

Warning: These citations may not always be 100% accurate.